Reaction of 3-phenylamino-2-thioxo-3H-quinazolin-4-one (1) with methyl iodide, α-chloroethylacetate, and α-bromobenzoylacetophenone in methanol in the presence of KOH with heating resulted in alkylation on the sulfur atom to 2-alkyl thio derivatives 2–4, respectively. Treatment of 1 with α-bromo-α-cyanoethylacetate afforded 3-hydroxy-10-oxo-4-phenyl-4H,10H-1-thia-4,4a,9-triaza-anthrancene-2-carbonitrile (5). Reaction of the ester 3 with hydrazine hydrate afforded hydrazide 6. The hydrazide 6 on reaction with benzoylacetone, dibenzoylmethane, and ethyl acetoacetate furnished the corresponding pyrazoles 7 and 8 and pyrazolone 9 respectively. Treatment of 6 with methanolic KOH and carbon disulphide afforded 1,3,4-oxadiazole-2-thione derivative 10. Compound 1 reacted namely with 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosylbromide, 2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl bromide, or with 2,3,4-tri-O-acetyl-α-D-xylopyranosyl bromide to yield S-glycoside derivatives 11–13, respectively. Oxidation of S-glucoside 11 with H 2 O 2 afforded the corresponding sulphone; 2-(2′,3′,4′,6′-tetra-O-acetyl-β-D-glucopyranosylsulphonyl)-3-phenlyamino-3H-quinazolin-4-one (14). The synthesized compounds have been screened for their antimicrobial activity.
No takes yet. Share an insight, caveat, or question.
Saleh et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: